|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.61 CNY | +1.14% |
|
-1.12% | +5.62% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 4.84% | 5.34% | 14.28x | 2.67x | 0.59x | 4.7x | 7.76x | 3.13B | |
| -.--% | -.--% | 17.76x | 1.57x | 0.74x | 11.69x | 12.55x | 15.37B | |
| 0.98% | 1.22% | 23.25x | 2.57x | 0.92x | 16.27x | 16.53x | 7.03B | |
| 2.28% | 2.61% | 16.4x | 1.72x | 0.74x | 7.64x | 9.65x | 6.02B | |
| 3.06% | 3.37% | 14x | 2.1x | 0.9x | 6.49x | 8.5x | 3.96B | |
| 5.36% | 6.09% | 14.28x | 4.37x | 1.22x | 7.44x | 13.99x | 3.23B | |
| 4.34% | 4.76% | 14.79x | 6.69x | 0.89x | 6.72x | 9.34x | 3B | |
| 1.9% | 2.31% | 21.58x | 3.78x | 0.62x | 8x | 13.09x | 1.55B | |
| 0.01% | -.--% | -93.08x | 2.93x | 0.46x | 17.21x | 104.56x | 1.53B | |
| 4.18% | 4.71% | 12.13x | 0.87x | 0.29x | 2.79x | 5.75x | 961M | |
| 5.76% | 5.57% | 14.5x | 2.4x | 0.85x | 6.91x | 14.87x | 919M | |
| 1.37% | 1.98% | 26.15x | 7.13x | 0.95x | 12.91x | 20.01x | 782M | |
| 0.34% | 0.36% | 15.07x | 2.04x | 0.71x | 8.74x | 14.11x | 733M | |
| Average | 2.65% | 2.95% | 8.55x | 3.14x | 0.76x | 9.04x | 19.29x | 3.71B | |
| Weighted average by Cap. | 1.9% | 2.14% | 13.96x | 2.57x | 0.80x | 10.14x | 15.01x |
Select your edition
All financial news and data tailored to specific country editions
